Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Indegene

Brextinction

Evolution predicts tragic consequences from the UK's choice

- PMLiVE

UK pharma faces ‘immediate challenges’ following Brexit

Life science sector awaits fallout from vote to leave the European Union

- PMLiVE

Industry welcomes European diagnostics regulations

Trade bodies say they will support greater use of personalised medicines

The death of deference

We are entering an age when authority matters less

UK flag

UK needs ‘Brexit contingency plan’ to protect its science base

Action must be taken to safeguard life sciences in the country, say MPs

The fifth estate

How the media reports on the pharma industry

- PMLiVE

Explosive evolution

Companies are being forced to diversify and specialise their business models

Legal developments in product liability

With restrictive legislation and recent landmark cases, the medical industry is under increasing legal pressure

Healthcare business and operating models redefined

How critical healthcare needs can be met more efficiently and effectively

- PMLiVE

Better insights come from better evidence

With the current data overload, it is critical that marketers have data literacy

- PMLiVE

The growing necessity for pharma to become a true health delivery partner of the NHS

Focus on solving your customer’s biggest problems to create shared value

- PMLiVE

European sites

What makes a country in Europe attractive to life science companies?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links